|
| |
NAEJA Pharmaceutical Inc.NEAJA Pharmaceutical Inc. is a private Canadian company created from the acquisition of assets from SynPhar Laboratories Inc.,(founded 1987) and a merger with DrisCorp Inc., a contract research company performing pre-clinical lead optimization medicinal chemistry.SynPhar Laboratories was a joint venture Alberta company between Taiho Pharma. Co. Ltd, Japan (Otsuka) and Dr. R.G. Micetich, Alberta, Canada and was established as an early stage pharmaceutical R&D company for the discovery of new drugs and to move them to the preclinical and IND stages. SynPhar holds over 100 patents in various disease areas and has established many compounds in various developmental stages.
| Contact Details: |
| 4290-91A Street |
| Edmonton |
| Alberta |
| T6E 5V2 |
| Canada |
| Tel: | (780) 462-4044 |
| Fax: | (780) 461-0196 |
| Email: | info@naeja.com |
| WWW: | www.naeja.com/

|
|
Loading...
|
Recent Publications by NAEJA Pharmaceutical Inc.: |  |
2-Aminoquinazoline inhibitors of cyclin-dependent kinases.
The inhibition of cyclin-dependent kinase 4 (Cdk4) causes cell cycle... | 19th October, 2005
| NAEJA Pharmaceutical Inc., #2, 4290-91A Street, Edmonton, Alberta, Canada
| Bioorg Med Chem Lett. 2005 Sep 1;15(17):3881-5.
DOI Direct Link |
4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives as anti-tumor agents.
A series of naturally occurring and synthetic novel oxapenam... | 22nd May, 2004
| Naeja Pharmaceutical Inc., 4290-91 A Street, Edmonton, Alberta, CANADA T6E
| Curr Med Chem Anticancer Agents. 2003 Nov;3(6):431-8.
|
3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
A new class of inhibitors for cysteine proteases cathepsin B, L, K and S... | 18th June, 2003
| SynPhar Laboratories, currently NAEJA Pharmaceutical Inc., 4290-91A
| Bioorg Med Chem Lett. 2003 Jan 6;13(1):139-41.
|
6-Acylamino-penam derivatives: synthesis and inhibition of cathepsins B, L, K, and S.
The synthesis of a new series of 6-acylamino penam derivatives and their... | 21st May, 2003
| SynPhar Laboratories, currently NAEJA Pharmaceutical Inc., Edmonton,
| Bioorg Med Chem Lett. 2002 Dec 2;12(23):3417-9.
|
Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitors.
A series of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one... | 21st May, 2003
| SynPhar Laboratories, currently NAEJA Pharmaceutical Inc., 4290-91A
| Bioorg Med Chem Lett. 2002 Dec 2;12(23):3413-5.
|
→View more NAEJA Pharmaceutical Inc. research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 616 times since April 2007, the link to the organisation's website has been followed 137 times Recent Search Terms used to find this page: NAEJA edmonton | neaja alberta | naeja pharmaceutical edmonton | Naeja Pharmaceuticals Inc. Edmonton Alta. Canada T6E 5V2 | neaja-edmonton | neaja pharma | edmonton pharmaceutical factory | naeja | naeja | naeja | . Search for more companies in Edmonton Search for more companies in Alberta This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for NAEJA Pharmaceutical Inc. |